Byrne Financial Freedom’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$871K Sell
3,428
-366
-10% -$85.3K 0.34% 52
2026
Q1
$927K Buy
3,794
+245
+7% +$57.1K 0.44% 43
2025
Q4
$735K Buy
3,549
+141
+4% +$27.9K 0.34% 50
2025
Q3
$632K Buy
3,408
+9
+0.3% +$1.54K 0.31% 50
2025
Q2
$519K Buy
3,399
+10
+0.3% +$1.54K 0.26% 57
2025
Q1
$562K Sell
3,389
-45
-1% -$7.04K 0.32% 51
2024
Q4
$497K Buy
+3,434
New +$532K 0.22% 56

Other funds holding JNJ

Byrne Financial Freedom's JNJ Position: Q2 2026 in Review

Byrne Financial Freedom reduced its Johnson & Johnson (JNJ) stake by 9.6% in Q2 2026, selling an estimated $85.3K and leaving 3,428 shares worth $871K. The position accounts for 0.34% of the portfolio, ranked #52.

Byrne Financial Freedom first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $927K in Q1 2026. 4,682 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Byrne Financial Freedom held 3,428 shares of Johnson & Johnson worth $871K as of Q2 2026.
  • Byrne Financial Freedom sold 366 Johnson & Johnson shares in Q2 2026, an estimated $85.3K.
  • Johnson & Johnson made up 0.34% of Byrne Financial Freedom's portfolio in Q2 2026, its #52 holding.
  • Byrne Financial Freedom first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Byrne Financial Freedom's Johnson & Johnson position peaked at $927K in Q1 2026.
  • 4,682 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Byrne Financial Freedom's 13F filing for Q2 2026, filed 30 Jul 2026.